Final Programme - iuphar

FC04 Pharmacoepidemiology, current controversies and
opportunities
Leaders: Bert Leufkens, (The Netherlands) & Jesper Hallas, (Denmark)
FC04.3 Regulatory challenges in managing risk of medicinal products
Leaders: Bert Leufkens, (The Netherlands) & Jesper Hallas, (Denmark)
09:30 - 09:55 FC04.3.1 What are the issues driving the regulatory agenda on drug safety and risk management?
June M Raine, (UK)
09:55 - 10:20 FC04.3.2 Are the available research methods sufficiently valid to address current benefit-risk
issues on medicinal products?
Stephen JW Evans, (UK)
10:20 - 10:45 FC04.3.3 New approaches to fill the methods gap in pharmacovigilance
Marieke de Bruin, (The Netherlands)
10:45 - 11:15 COFFEE BREAK
11:15 - 11:30 FC04.3.4 Free Communication Presentation:
Prescription drug use during pregnancy in Estonia
Alar Irs, (Estonia), J Iljuhhina, O Laius, J Lass
11:30 - 11:45 FC04.3.5 Free Communication Presentation:
Cannabis-related adverse events: A hospitalization-based pharmacoepidemiological study
Émilie Jouanjus, (France), F Leymarie, M Tubéry, M Lapeyre-Mestre
11:45 - 12:00 FC04.3.6 Free Communication Presentation:
Bisphosphonates Effectiveness Safety Tradeoff (BEST)
Francesco Lapi, (Italy), G Corrao, N Montanaro, M Sturkenboom, P Geppetti, D Gregori,
F Carle, A Menna, A Caputi, A Vestri, M Valenti, G Mazzaglia
12:00 - 12:15 FC04.3.7 Free Communication Presentation:
A model for prediction of adverse drug reactions in hospitalized patients
Thiyagu Rajakannan, (India), V Guddattu, SR Mallayasamy, R Vilakkthala, S Kamath,
LK Bairy, PGM Rao
Tuesday 20 July ■ 09:30 - 12:15 ■ Auditorium 11 65